SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001571049-17-002946
Filing Date
2017-03-28
Accepted
2017-03-28 16:15:20
Documents
4
Period of Report
2017-03-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K t1700895_8k.htm 8-K 17086
2 EXHIBIT 99.1 t1700895_ex99-1.htm EX-99.1 85604
3 GRAPHIC t1700895_ex99-1logo.jpg GRAPHIC 10130
4 GRAPHIC t1700895_ex99-1logo1.jpg GRAPHIC 3312
  Complete submission text file 0001571049-17-002946.txt   122758
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 17719140
SIC: 2834 Pharmaceutical Preparations